A court has approved a $64 million settlement in a consumer class action against the NAB units MLC Trustees and NULIS Nominees, with 69 per cent of the settlement sum to go to group members.
A class action against CMC Markets has won access to data thought to reveal that approximately 2,500 customers who failed screening tests for risky financial products were nevertheless permitted to trade.
A court has dismissed a client’s attempt to join Kheir Lawyers to an action against Shine Lawyers, after the application — repleaded for a fourth time — remained “indefensible”.
Petrol giant Ampol has announced it is exiting the retail electricity market in Australia and New Zealand, divesting its assets to AGL and Meridian to direct its focus towards electric vehicle charging and renewable fuels.
Ex-CFMEU Victorian branch boss John Setka has still not filed his defence in a case alleging he tried to get the former head of the construction industry watchdog sacked, and the Fair Work Ombudsman says it may seek summary judgment.
An appeals court has rejected Keybridge CEO Nick Bolton’s challenge to a ruling that found that he and two other directors were validly removed at a board meeting, finding in favour of shareholder WAM Active.
The High Court has been asked to weigh in on whether issue and Anshun estoppel apply to SOP Act claims, with a South Australian wind farm seeking to overturn a ruling ordering it to make a $21 million progress payment to joint venture partners GE Renewable Energy and Elecnor.
Property investor ISPT has snapped up a 2.9 hectare shopping plaza in the Townsville suburb of Burdell, anticipating major growth in the area. On Thursday ISPT announced it had acquired Woolworths-anchored shopping precinct North Shore Marketplace from property fund manager Clarence Property, in an off-market deal through its retail property trust, IRAPT. ISPT fund manager…
The owners corporation of a 98-unit Parklea development by defunct builder Dyldam Developments has failed in its attempt to claim insurance for building defects in a property completed 17 years ago, with a court finding that time was up.
Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen’s bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.